Key result
Adding CABG to surgical aortic valve replacement in octogenarians was associated with higher mortality within 1 year (HR 1.17; 95% CI 1.01-1.36) but similar long-term survival (HR 0.95).
Why the study?
Long-term outcomes comparing octogenarian patients undergoing isolated surgical aortic valve replacement versus CABG combined with SAVR remain debated.
Does CABG added to SAVR improve overall long-term survival compared to isolated SAVR in octogenarian patients?
Meta-Analysis (n=5,382)
Does CABG added to SAVR improve overall long-term survival compared to isolated SAVR in octogenarian patients?
Hazard Ratio: 0.95 (95% CI 0.87–1.04)
p-value: p=0.35
In octogenarians undergoing SAVR, concomitant CABG increases early mortality (within 1 year) without providing a significant long-term survival benefit compared to isolated SAVR.
Concomitant CABG warrants caution in octogenarians undergoing SAVR; leaves open whether randomized data would confirm any long-term survival impact.
The long-term results in studies comparing octogenarian patients who received either isolated surgical aortic valve replacement (i-SAVR) or coronary artery bypass grafting (CABG) in addition to SAVR are still debated. We performed a reconstructed time-to-event data meta-analysis of studies comparing i-SAVR and CABG+SAVR to evaluate the impact of CABG and to analyse the time-varying effects on long-term outcome. We performed a systematic review of the literature from January 2000 through November 2021, including studies comparing i-SAVR and CABG+SAVR, which reported at least 3-year follow-up and that plotted Kaplan-Meier curves of overall survival. The primary endpoint was overall long-term survival; secondary endpoints were in-hospital/30-day mortality and postoperative outcomes. The pooled hazard ratio (HR) and odds ratio) with 95% confidence interval (CI) were calculated for primary and secondary endpoints, respectively. Random-effect model was used in all analyses. Sixteen retrospective studies were included (5382 patients, i-SAVR = 2568 and CABG+SAVR = 2814). I-SAVR showed a lower incidence of in-hospital mortality compared to CABG+SAVR (odds ratio = 0.73; 95% CI= 0.60-0.89; P = 0.002). Landmark analyses showed a significantly higher all-cause mortality within 1 year from surgery in CABG+SAVR (HR = 1.17; 95% CI = 1.01-1.36; P = 0.03); after 1 year, no significant difference was observed (HR = 0.95; 95% CI = 0.87-1.04; P = 0.35). Landmark analysis was confirmed by time-varying trend of HR. Late survival of octogenarians did not differ significantly between the 2 interventions. Interestingly, CABG added to SAVR was associated with both higher in-hospital and within 1-year mortality after surgery, whereas this difference was statistically non-significant at long-term follow-up.
No takes yet. Share an insight, caveat, or question.
Gallingani et al. (2022) conducted a meta-analysis in Aortic valve disease with or without coronary artery disease in octogenarians (n=5,382). CABG added to SAVR vs. Isolated surgical aortic valve replacement (i-SAVR) was evaluated on Overall long-term survival (HR 0.95, 95% CI 0.87-1.04, p=0.35). Adding CABG to surgical aortic valve replacement in octogenarians was associated with higher mortality within 1 year (HR 1.17; 95% CI 1.01-1.36) but similar long-term survival (HR 0.95).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: